General Information of Drug (ID: DMES7JY)

Drug Name
Midecamycin
Synonyms
midecamycin; Mydecamycin; Medemycin; Turimycin P3; Antibiotic SF 837; SF 837; YL 704 B1; 35457-80-8; Antibiotic YL 704B1; Antibitotic YL-704 B1; Prestwick_515; Antibiotic SF-837; AC1NTK8S; Prestwick2_000153; Leucomycin V,4B-dipropanoate; HMS1568O08; NSC154011; NSC-154011; LEUCOMYCIN V - RELATED TO D239737 - MEIJI SEIKA
Indication
Disease Entry ICD 11 Status REF
Bacterial infection 1A00-1C4Z Approved [1]
Affected Organisms
Gram-positive BacteriaBordetella pertussisCorynebacterium diphtheriaeStreptococcus pneumoniaeHaemophilus influenzaeStaphylococcus haemolyticusMycoplasma pneumoniae
ATC Code
J01FA03: Midecamycin
J01FA: Macrolides
J01F: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01: ANTIBACTERIALS FOR SYSTEMIC USE
J: ANTIINFECTIVES FOR SYSTEMIC USE
J01FA03: Midecamycin
J01FA: Macrolides
J01F: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01: ANTIBACTERIALS FOR SYSTEMIC USE
J: ANTIINFECTIVES FOR SYSTEMIC USE
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C41H67NO15
Canonical SMILES
CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C
InChI
InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1
InChIKey
DMUAPQTXSSNEDD-QALJCMCCSA-N
Cross-matching ID
PubChem CID
5282169
ChEBI ID
CHEMBL444963
CAS Number
35457-80-8
UNII
N34Z0Y5UH7
DrugBank ID
DB13456
TTD ID
D0J7OG
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015